Home > Financial Ratios > CIPLA

CIPLA
Core EBITDA Growth

    Back to All Ratios
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -15.3313.5327.9013.836.98

What is the latest Core EBITDA Growth ratio of CIPLA ?

The latest Core EBITDA Growth ratio of CIPLA is -15.33 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026-15.33
Mar202513.53
Mar202427.90
Mar202313.83
Mar20226.98

How is Core EBITDA Growth of CIPLA Trending?

Years Core EBITDA Growth % Change
Mar2026 -15.33
Negative
Mar2025 13.53
-51.51
Mar2024 27.9
101.74
Mar2023 13.83
98.14
Mar2022 6.98 -

Other Financial Ratios of CIPLA


Compare Core EBITDA Growth ratio of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹112,879.8 Cr 0.9% -0.8% -10.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -2.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹255,115.0 Cr 1.9% 6.6% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,613.0 Cr 0.3% 2% 35.9% Stock Analytics
MANKIND PHARMA ₹102,247.0 Cr 1.9% 3.5% -7% Stock Analytics
DR REDDYS LABORATORIES ₹100,395.0 Cr 0.1% 1.4% -9.3% Stock Analytics


CIPLA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

0.9%

-0.8%

-10.9%

SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses